Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1Classical hematology 1

Conditions

Ulcer 1Stomatitis 1Stomach Neoplasms 1Speech 1Radiation Injuries 1Pain 1Neuroendocrine Tumors 1Mucositis 1Head and Neck Neoplasms 1Anemia, Iron-Deficiency 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 71apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × Betaine × Clear all
NCT06881511 2025-03-30

Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Recruiting
100 enrolled
Classical hematologyEndocrineGastrointestinalNET

Stomach Neoplasms, Neuroendocrine Tumors, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡